UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity

Blood, 2012-04, Vol.119 (16), p.3734-3743

2012

Volltextzugriff (PDF)

Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion

Nature communications, 2019-02, Vol.10 (1), p.728-12, Article 728

2019

Volltextzugriff (PDF)

Hide and seek: for HIV-infected CD4+ T cells, playing well comes with maturity

The Journal of clinical investigation, 2022-04, Vol.132 (7), p.1-4

2022

Volltextzugriff (PDF)

Suboptimal Biological Sampling as a Probable Cause of False-Negative COVID-19 Diagnostic Test Results

The Journal of infectious diseases, 2020-08, Vol.222 (6), p.899-902

2020

Volltextzugriff (PDF)

Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells

The Journal of clinical investigation, 2018-02, Vol.128 (2), p.876-889

2018

Volltextzugriff (PDF)

Tissue memory CD4+ T cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection

PLoS pathogens, 2020-04, Vol.16 (4), p.e1008450-e1008450

2020

Volltextzugriff (PDF)

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8 + T cell immunity

Nature communications, 2022-10, Vol.13 (1), p.6473-6473, Article 6473

2022

Volltextzugriff (PDF)

BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo

The Journal of clinical investigation, 2020-05, Vol.130 (5), p.2542-2559

2020

Volltextzugriff (PDF)

Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure

Frontiers in immunology, 2018-06, Vol.9, p.1452-1452

2018

Volltextzugriff (PDF)

In Vitro and In Vivo Models of HIV Latency

HIV Vaccines and Cure, p.241-263

Volltextzugriff (PDF)

Human splice factors contribute to latent HIV infection in primary cell models and blood CD4+ T cells from ART-treated individuals

PLoS pathogens, 2020-11, Vol.16 (11), p.e1009060-e1009060

2020

Volltextzugriff (PDF)

Telescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression

PLoS computational biology, 2019-09, Vol.15 (9), p.e1006453

2019

Volltextzugriff (PDF)

Roles of fragment crystallizable-mediated effector functions in broadly neutralizing antibody activity against HIV

Current opinion in HIV & AIDS, 2020-09, Vol.15 (5), p.316-323

2020

Volltextzugriff (PDF)

A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes

PLoS pathogens, 2016-04, Vol.12 (4), p.e1005545-e1005545

2016

Volltextzugriff (PDF)

HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

Nature communications, 2021-01, Vol.12 (1), p.165-165, Article 165

2021

Volltextzugriff (PDF)

T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy

PLoS pathogens, 2017-09, Vol.13 (9), p.e1006629-e1006629

2017

Volltextzugriff (PDF)

Modeling HIV-1 Latency Using Primary CD4 + T Cells from Virally Suppressed HIV-1-Infected Individuals on Antiretroviral Therapy

Journal of virology, 2019-06, Vol.93 (11)

2019

Volltextzugriff (PDF)

HIV reservoirs are dominated by genetically younger and clonally enriched proviruses

mBio, 2023-12, Vol.14 (6), p.e0241723

2023

Volltextzugriff (PDF)

HTLV-1 as a Model for Virus and Host Coordinated Immunoediting

Frontiers in immunology, 2019-09, Vol.10, p.2259-2259

2019

Volltextzugriff (PDF)

No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ART

AIDS (London), 2022-10, Vol.36 (12), p.1617-1628

2022

Volltextzugriff (PDF)

Susceptibility to Neutralization by Broadly Neutralizing Antibodies Generally Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs

Journal of virology, 2018-12, Vol.92 (23)

2018

Volltextzugriff (PDF)

Antiviral CD8+ T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal Expansion

Immunity (Cambridge, Mass.), 2016-10, Vol.45 (4), p.917-930

2016

Volltextzugriff (PDF)

Persistent HIV RNA shedding in semen despite effective antiretroviral therapy

AIDS (London), 2009-09, Vol.23 (15), p.2050-2054

2009

Volltextzugriff (PDF)

HIV-1 subtype A1, D, and recombinant proviral genome landscapes during long-term suppressive therapy

Nature communications, 2024-07, Vol.15 (1), p.5480-10, Article 5480

2024

Volltextzugriff (PDF)

1 – 25 von 478

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(456)
Mit Volltextzugriff
(427)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity

Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion

Hide and seek: for HIV-infected CD4+ T cells, playing well comes with maturity

Suboptimal Biological Sampling as a Probable Cause of False-Negative COVID-19 Diagnostic Test Results

Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells

Tissue memory CD4+ T cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection

Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8 + T cell immunity

BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo

Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure

In Vitro and In Vivo Models of HIV Latency

Human splice factors contribute to latent HIV infection in primary cell models and blood CD4+ T cells from ART-treated individuals

Telescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression

Roles of fragment crystallizable-mediated effector functions in broadly neutralizing antibody activity against HIV

A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes

HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)

T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy

Modeling HIV-1 Latency Using Primary CD4 + T Cells from Virally Suppressed HIV-1-Infected Individuals on Antiretroviral Therapy

HIV reservoirs are dominated by genetically younger and clonally enriched proviruses

HTLV-1 as a Model for Virus and Host Coordinated Immunoediting

No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ART

Susceptibility to Neutralization by Broadly Neutralizing Antibodies Generally Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs

Antiviral CD8+ T Cells Restricted by Human Leukocyte Antigen Class II Exist during Natural HIV Infection and Exhibit Clonal Expansion

Persistent HIV RNA shedding in semen despite effective antiretroviral therapy

HIV-1 subtype A1, D, and recombinant proviral genome landscapes during long-term suppressive therapy

HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapy

Suchergebnisse filtern